SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : IMDS nasdaq bulletin board

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jwk who wrote (2984)3/28/1999 4:18:00 PM
From: Dan O  Read Replies (2) of 4122
 
Its Sunday, a good time to review. For those of you not familiar with the MASSIVE concerns with this company's management, please read posts 2636 thru 2640 and post 2661. They show how shareholders have been mislead, how the company has been mismanaged and how management has consistently put their own interests ahead of the common shareholder. And what do the critics want? Its SO DARN SIMPLE. Only a family member of the insiders or a paid mouthpiece of the insiders would object to these very reasonable requests:

1. Grable should surrender the reversion rights for the patent license that he received under the oral agreement that was never disclosed.

2. Grable should surrender the 7 million shares he received under the oral agreement that was never disclosed.

3. Grable should surrender the DOUBLING of his royalty rate under the newly memorialized deal.

4. Grable should surrender the anti-dilution protection which none of us have.

5. An independent shareholder committee that is NOT controlled by insiders should determine compensation practices and approve transactions with related parties.

6. Executive salaries should be cut back to 1996 levels and all benefits should be frozen until FDA approval is received.

7. The company should adopt a prospective policy against nepotism and touting in case they have been problems in the past.

8. The company should make a clear and accurate statement regarding the charges made regarding their history with Lintronics.

9. The company should make a clear statement clarifying the international sales timing since the public filings seem to tell a different story than the press releases and message board posts.

10. No officer should be allowed to sell stock until after FDA approval.

11. A committment must be made never to sell guaranteed profit convertibles to entities owned or operated by insiders or their relatives

12. The company should simply admit the Deb relationship if it is true. IF so, they should explain why they have denied it in the past.

13. The company should commit to spending less resources on trade shows or other STOCK SELLING EFFORTS and should focus more time on the FDA, improving the product, and generating overseas sales.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext